Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Stopped Study has been cancelled and it has not been initiated.

Conditions

• Post-menopausal Period

Interventions

• DRUG: Testosterone gel 1% 2.2 mg
• DRUG: Testosterone gel 1% 4.4 mg
• DRUG: Testosterone gel 1% 8.8 mg
• DRUG: Placebo of Testosterone Gel 1%

Sponsor

Biolab Sanus Farmaceutica